Featured Research

from universities, journals, and other organizations

Gene therapy for ears

Date:
December 21, 2011
Source:
The Norwegian University of Science and Technology (NTNU)
Summary:
Gene therapy may someday in the future replace the use of implants in deaf people. The carrier for this gene medicine may be derived from shrimp shells.

Normal hearing depends on the presence of healthy hair cells in the inner ear. Gene therapy has the potential to slow the loss of hair cells and promote the growth of hair cells that have already been damaged.

In gene therapy, genetic material -- DNA or RNA -- is transported by a carrier to cells to provide instructions for and replace damaged genes. The carrier must protect its genetic package and help it make its way through the membranes that protect cells and their surroundings. The carrier should also be able to transport the genetic material right to the cells that need help.

For the first time ever, chitosan nanoparticles have been used as a carrier for gene therapy in the ear. Chitosan is produced from shrimp shells.

"Gene therapy may someday be an alterna­tive to using surgery to implant CI, cochlear implants, in the deaf and hard of hearing," says Sabina Strand, at NTNU's Department of Biotechnology.

Basic research promising

Strand studies the use of chitosan in gene therapy, and conducted this basic research, now ended, in cooperation with the Karolinska Institutet in Sweden. Here, researchers attempted to use chitosan as a carrier to deliver drugs and genes to the inner ear in guinea pigs. Chitosan was able to deliver drugs through the membrane that covers the tiny gap between the middle ear and inner ear. Chitosan was also able to deliver genes to the hair cells. Whether or not the results from guinea pigs can be transferred to human ears remains uncertain.

"However, chitosan is non-toxic and is not harmful to cells. Chitosan is therefore better than other carriers and has characteristics that mean it could potentially be used with patients," says Strand.

Tidy packages

Chitosan is produced from powdered shrimp shells. Acid removes salts, minerals and calcium carbonate. Strong alkalis and heat remove proteins. What remains is chitosan.

Extremely small nanoparticles in the range of 50-200 nm (nanometres) are formed spon­taneously when the positively charged chitosan and negatively charged genes are mixed. Chitosan does a good job packaging up DNA and RNA's relatively large molecules.

Tailored therapy

In the body, chitosan attaches itself to molecules, cells and membranes. When the nanoparticles have passed through a membrane, chitosan packages up the gene molecules so they return to their normal size again. Chitosan also creates gaps between cells, which facilitate the absorption of medicine.

Different forms of gene therapy require nanoparticles with different properties. The properties of nanoparticles are controlled by the way in which researchers tailor the chitosan structure, its molecular size and 3D architecture. But whether or not researchers will find the perfect mix of medicines for our ears and hair cells remains to be seen -- and heard.


Story Source:

The above story is based on materials provided by The Norwegian University of Science and Technology (NTNU). Note: Materials may be edited for content and length.


Cite This Page:

The Norwegian University of Science and Technology (NTNU). "Gene therapy for ears." ScienceDaily. ScienceDaily, 21 December 2011. <www.sciencedaily.com/releases/2011/12/111219135021.htm>.
The Norwegian University of Science and Technology (NTNU). (2011, December 21). Gene therapy for ears. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2011/12/111219135021.htm
The Norwegian University of Science and Technology (NTNU). "Gene therapy for ears." ScienceDaily. www.sciencedaily.com/releases/2011/12/111219135021.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) — Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) — Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) — At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) — Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins